Concepedia
Statistics
Publications
14
Citations
753
H-Index
12
Active since
1988
Affiliations
University of Toronto(Current)
Toronto General Hospital
Sunnybrook Health Science Centre
Sunnybrook Research Institute
Sunnybrook Hospital
Mary Hill is an author at University of Toronto specializing in life sciences, signal transduction, and neurodegenerative diseases.
Publications per year
1988–2022
Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV
Daniel J. Drucker, Qing Shi, Anna Crivici et al. · Nature Biotechnology · 1997 · 278 citations
Life Sciences, Biochemistry, Molecular Biology +8
Essential Requirement for<i>Pax</i>6 in Control of Enteroendocrine Proglucagon Gene Transcription
Mary Hill, L. Sylvia, Daniel J. Drucker · Molecular Endocrinology · 1999 · 129 citations · Full text
Life Sciences, Endocrinology, Physiology +17
Regional differences in Alzheimer’s disease pathology confound behavioural rescue after amyloid-β attenuation
Christopher D. Morrone, Paolo Bazzigaluppi, Tina L. Beckett et al. · Brain · 2019 · 62 citations · Full text
Life Sciences, Neurobiology, Neuroscience +17
Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action.
Louise A. Scrocchi, Mary Hill, Jumana Saleh et al. · Diabetes · 2000 · 59 citations
Suramin prevents binding of interleukin 2 to its cell surface receptor: a possible mechanism for immunosuppression.
Gordon B. Mills, Nan Zhang, Christopher May et al. · PubMed · 1990 · 57 citations
Life Sciences, Immunology, Pharmacology +10
1–5 of 14